Yasuaki Yamakawa

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Optical Coherence Tomography

Thoracic Surgery

Prognostic Factors

Insulin Resistance

Top Venues

Journal of personalized medicine

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuaki Yamakawa, Norio Yamamoto, Yosuke Tomita, Ryuichiro Okuda, Yasutaka Masada, Akihiro Shiroshita, Toshiyuki Matsumoto
Reliability of the Garden Alignment Index and Valgus Tilt Measurement for Nondisplaced Femoral Neck Fractures. Journal of personalized medicine 13 (1) (2022)
Yasuaki Yamakawa, Norio Yamamoto, Yosuke Tomita, Ryuichiro Okuda, Yasutaka Masada, Akihiro Shiroshita, Toshiyuki Matsumoto
Reliability of the Garden Alignment Index and Valgus Tilt Measurement for Nondisplaced Femoral Neck Fractures. Journal of personalized medicine 13 (1) (2022)
Yasuaki Yamakawa, Norio Yamamoto, Yosuke Tomita, Ryuichiro Okuda, Yasutaka Masada, Akihiro Shiroshita, Toshiyuki Matsumoto
Reliability of the Garden Alignment Index and Valgus Tilt Measurement for Nondisplaced Femoral Neck Fractures. Journal of personalized medicine 13 (1) (2022)
Yasuaki Yamakawa, Norio Yamamoto, Yosuke Tomita, Ryuichiro Okuda, Yasutaka Masada, Akihiro Shiroshita, Toshiyuki Matsumoto
Reliability of the Garden Alignment Index and Valgus Tilt Measurement for Nondisplaced Femoral Neck Fractures. Journal of personalized medicine 13 (1) (2022)
Yasuaki Yamakawa, Norio Yamamoto, Yosuke Tomita, Ryuichiro Okuda, Yasutaka Masada, Akihiro Shiroshita, Toshiyuki Matsumoto
Reliability of the Garden Alignment Index and Valgus Tilt Measurement for Nondisplaced Femoral Neck Fractures. Journal of personalized medicine 13 (1) (2022)
Kazuhisa Sugiu, Hiroshi Tazawa, Joe Hasei, Yasuaki Yamakawa, Toshinori Omori, Tadashi Komatsubara, Yusuke Mochizuki, Hiroya Kondo, Shuhei Osaki, Tomohiro Fujiwara, Aki Yoshida, Toshiyuki Kunisada, Koji Ueda, Yasuo Urata, Shunsuke Kagawa, Toshifumi Ozaki, Toshiyoshi Fujiwara
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression. Cancer chemotherapy and pharmacology 88 (3) (2021)